Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome (MEPOCHUSS)

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Moosig, University of Schleswig-Holstein
ClinicalTrials.gov Identifier:
NCT00716651
First received: July 14, 2008
Last updated: June 14, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)